National Health Investors (NHI) is a publicly traded Real Estate sector company. As of November 9, 2026, NHI trades at $69.45 with a market cap of $3.50B and a P/E ratio of 18.78. NHI moved -0.34% today. Year to date, NHI is -7.20%; over the trailing twelve months it is -7.14%. Its 52-week range spans $63.51 to $91.38. Analyst consensus is strong buy with an average price target of $80.50. Rallies surfaces NHI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NHI cuts 2026 FFO outlook as Q3 normalized FFO per share falls 15%: National Health Investors expects 2026 NAREIT FFO of $4.68 to $4.70 per diluted share and FAD of $236.6 million to $237.7 million. Q3 normalized FFO per share fell 15% year over year to $1.12, while net income rose on the NHC portfolio sale gain.
| Metric | Value |
|---|---|
| Price | $69.45 |
| Market Cap | $3.50B |
| P/E Ratio | 18.78 |
| EPS | $3.47 |
| Dividend Yield | 0.94% |
| 52-Week High | $91.38 |
| 52-Week Low | $63.51 |
| Volume | 285.22K |
| Avg Volume | 0 |
| Revenue (TTM) | $432.12M |
| Net Income | $165.39M |
| Gross Margin | 0.00% |
6 analysts cover NHI: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $80.50.